KIRKLAND, Wash., March 07, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS) (“Kestra”), a wearable medical device and digital healthcare company, announced today the closing of its upsized initial public offering of 11,882,352 common shares at a public offering price of $17.00 per share. The total gross [...]
Sudden Cardiac Arrest (SCA) is a life-threatening condition affecting hundreds of thousands of individuals each year, particularly those with low Left Ventricular Ejection Fraction (LVEF). While wearable cardioverter defibrillators (WCDs) are a well-established therapy for preventing SCA, adherence rates are often low. Kestra Medical Technologies is tackling this issue with [...]
Kestra Medical Technologies Ltd., a prominent name in the wearable medical devices sector, has officially filed for an initial public offering (IPO), showcasing a remarkable surge in revenue that has nearly tripled. The Bloomberg report highlights that the company is poised to offer new shares as part of this [...]
The financing secured will drive growth and accelerate commercial expansion efforts, support the scaling of commercial teams and outreach initiatives to bring CeQur Simplicity™, its 4-day wearable insulin delivery device, to more healthcare providers and patients managing diabetes. Horw, Switzerland, January 7, 2025 – CeQur®, a medical device company dedicated [...]
First backed by Endeavour Vision in 2015, Gynesonics is a women’s healthcare company focused on improving the treatment of uterine fibroids through its innovative Sonata® System. This minimally invasive technology provides a uterine-preserving option for symptomatic fibroids that offers women a faster, safer alternative to traditional surgical procedures. Hologic [...]
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, has completed its previously announced acquisition of Gynesonics, Inc. (Gynesonics®), a privately held medical device company focused on the development of minimally invasive solutions for women’s health, for approximately $350 million. “We are excited to complete [...]
MARLBOROUGH, Mass. 14 October--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), a global champion of women’s health, today announced that it has signed a definitive agreement to acquire Gynesonics, Inc. (Gynesonics®), a privately held medical device company focused on the development of minimally invasive solutions for women’s health for approximately $350 [...]
NEW BRUNSWICK, N.J.— October 9, 2024 — Johnson & Johnson1 (NYSE: JNJ) announced today it has successfully completed the acquisition of V-Wave Ltd., a privately-held company focused on developing innovative treatment options for patients with heart failure. V-Wave will operate as part of Johnson & Johnson MedTech. The acquisition [...]
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson1 (NYSE: JNJ) today announced that it has entered into a definitive agreement to acquire V-Wave Ltd., a privately-held company focused on developing innovative treatment options for patients with heart failure. Under the terms of the agreement, Johnson & Johnson will acquire V-Wave for [...]
SALT LAKE CITY, Aug. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has successfully completed its acquisition of Lumeon Limited ("Lumeon"), a digital health company with operations in the U.S. [...]